Reza Zadno - Mar 6, 2024 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
President, CEO, Director
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Reza Zadno, Ph.D.
Stock symbol
PRCT
Transactions as of
Mar 6, 2024
Transactions value $
-$428,384
Form type
4
Date filed
3/7/2024, 07:50 PM
Previous filing
Oct 18, 2023
Next filing
Mar 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Award $0 +54.9K +27.34% $0.00 256K Mar 6, 2024 Direct F1
transaction PRCT Common Stock Sale -$428K -9.18K -3.59% $46.67 247K Mar 6, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Award $0 +47.8K $0.00 47.8K Mar 6, 2024 Common Stock 47.8K $47.17 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2024, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on February 16, 2023.
F3 The price reported in Column 4 is a weighted average price.
F4 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.